Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from 24 February to 27 February 2016, Thomas Seufferlein, MD, from the University of Ulm, Ulm, Germany, summarises current treatment options, including new chemotherapy combinations, for pancreatic cancer and opportunities for developing novel therapies based on the improving understanding of the molecular processes underlying the development of the disease.
European Medical Journal
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Advertisement